In 1940, Wiedemann passed the state examination. With a doctoral thesis with Yusuf Ibrahim he was appointed doctor of medicine in 1941 in Jena.[1] In Jena, he wrote and researched jaundice.[2] He continued with specialist training in Bremen, Bonn and Münster.[3] As director of the Krefeld Children's Hospital, Wiedemann was one of the first to recognise the fatal side effects of thalidomide. While initially considered safe, thalidomide was responsible for teratogenic deformities in children born after their mothers used it during pregnancies, prior to the third trimester. In November 1961, thalidomide was taken off the market due to massive pressure from the press and public.[4][5][6][7]
The University of Kiel appointed Wiedemann in 1961 as Chairman of Pediatrics.[8] In 1977, he was chairman of the German Society for Paediatrics Medicine.[9] In 1980, he became professor emeritus.[10] Wiedemann collected and wrote several books about autographs with his wife Gisela von Sybel. [11]
The world of autographs - Gisela and Hans-Rudolf Wiedemann. German Schiller Society, Marbach am Neckar 1994.
References
^Dissertation: Zur Frage der kindlichen Bleivergiftung (Über einen Fall tödlich verlaufener Bleieklampsie und zwei Fälle von Bleieinwirkung bei Kleinkindern).
^Der konstitutionelle, familiäre, hämolytische Ikterus im Kindesalter (1946).
^Fritz Hilgenberg: Erlebte Kinderheilkunde. Beiträge zur Geschichte der Kinderklinik der Westfälischen Wilhelms-Universität Münster, gesammelt von Fritz Hilgenberg. Münster 1992, S. 32–37.
^Wiedemann, Hans-Rudolf: Hinweis auf eine derzeitige Häufung hypo- und aplastischer Fehlbildungen der Gliedmaßen. Medizinische Welt 37 (1961), S. 1863–1866.
^H.-R. Wiedemann: Beitrag zur Geschichte der Universitäts-Kinderklinik Kiel. Ansprachen und Reden an Gäste und Mitarbeiter 1963–1980.
^„Ein ganzes Heft Autographa!“ Die Sammlung Gisela und Hans-Rudolf Wiedemann. Katalog der Handschriften im Deutschen Literaturarchiv. ISBN978-3-929146-12-7.